In Nature this week: CRISPR-Cas9 genome editing system that does not require double-strand DNA breaks, and more.
In Science this week: somatic mutations found throughout normal tissue, and more.
The Columbia Solid Tumor Panel, a custom NGS panel from Pillar Biosciences, will be used at CUMC's Laboratory of Personalized Genomic Medicine.
A LIMS1 gene variant appeared to coincide with increased risk of allograft rejection in kidney transplant recipients.
Consumer genomics companies have endeavored to reach out to minority communities with sometimes contentious results.
In PNAS this week: core Pseudomonas aeruginosa genome, study of ancient Paget's disease of the bone, and more.
In Nature this week: genomic factors that influence glioblastoma response to anti-PD-1 therapy, sequencing test for infectious disease, and more.
A trio of researchers writes at Stat News that while editing embryos to improve IQ is not yet possible, there's already a way to predict which embryos might be the smartest.
Researchers identified PTEN mutations, MAP kinase pathway alterations, and other features linked to anti-PD-1 response in individuals with the brain cancer.
NPR reports on ongoing basic research involving CRISPR and human embryos in the US.
US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.
Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.
Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.
In Science this week: almond reference genome, and more.